Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Divestments (2018 - 2023)

Historic Divestments for Harvard Bioscience (HBIO) over the last 5 years, with Q1 2023 value amounting to $512000.0.

  • Harvard Bioscience's Divestments changed N/A to $512000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $512000.0, marking a year-over-year change of. This contributed to the annual value of $512000.0 for FY2023, which is N/A changed from last year.
  • Per Harvard Bioscience's latest filing, its Divestments stood at $512000.0 for Q1 2023.
  • Harvard Bioscience's 5-year Divestments high stood at $1.0 million for Q2 2019, and its period low was -$18000.0 during Q4 2019.